Therapeutic Solutions International, Inc., to Initiate Clinical Trial of Patented Cancer Immunotherapy Adjuvant … – GlobeNewswire (press release)
|
Therapeutic Solutions International, Inc., to Initiate Clinical Trial of Patented Cancer Immunotherapy Adjuvant …
GlobeNewswire (press release) OCEANSIDE, Calif., May 15, 2018 (GLOBE NEWSWIRE) — Via OTC PR Wire –Therapeutics Solutions International, Inc., (OTC Markets:TSOI) announced today Institutional Review Board (IRB) clearance to initiate a pilot pharmacokinetic trial of its nanoparticle … |
